Paper6286502
[Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].
Schwigon CD. Infection, 1982. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)]. Papers, record 6286502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6286502
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Infections | Major topic |
| Cefotaxime | Major topic |
| Critical Care | Major topic |
| Lung Diseases | Major topic |
| Penicillins | Major topic |
| Ticarcillin | Major topic |
| Aged | |
| Drug Combinations | |
| Female | |
| Furosemide | |
| Humans | |
| Kidney | |
| Male |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 422,252 | [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)]. | Infection | 1979 | https://conductscience.org/library/papers/422252 | PubMed |
| 2 | 6,252,153 | Cefotaxime in the treatment of lower respiratory tract infections. | J Antimicrob Chemother | 1980 | https://conductscience.org/library/papers/6252153 | PubMed |
| 3 | 4,871,700 | The importance of underlying disease in patients with gram-negative bacteremia. | Arch Intern Med | 1968 | https://conductscience.org/library/papers/4871700 | PubMed |
| 4 | 6,252,156 | Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study. | J Antimicrob Chemother | 1980 | https://conductscience.org/library/papers/6252156 | PubMed |
| 5 | 4,218,163 | [Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)]. | Dtsch Med Wochenschr | 1974 | https://conductscience.org/library/papers/4218163 | PubMed |
| 6 | 100,271 | Routine methods and their reliability for assessment of glomerular filtration rate in adults, with special reference to total [51Cr]EDTA plasma clearance. | Dan Med Bull | 1978 | https://conductscience.org/library/papers/100271 | PubMed |
| 7 | 437,897 | [In vitro testing of newer cephalosporins (author's transl)]. | Infection | 1979 | https://conductscience.org/library/papers/437897 | PubMed |
| 8 | 4,210,892 | Preliminary clinical experience with ticarcillin (BRL 2288) in 101 patients treated for severe respiratory infections. | Chemotherapy | 1974 | https://conductscience.org/library/papers/4210892 | PubMed |
| 9 | 1,086,018 | [Gentamicin and ototoxicity. A prospective study]. | Ugeskr Laeger | 1976 | https://conductscience.org/library/papers/1086018 | PubMed |
| 10 | 1,107,435 | Pharmacokinetics of ticarcillin in patients with abnormal renal function. | J Infect Dis | 1976 | https://conductscience.org/library/papers/1107435 | PubMed |
| 11 | 90,896 | Nephrotoxicity of cefotaxime. | Lancet | 1979 | https://conductscience.org/library/papers/90896 | PubMed |
| 12 | 1,095,500 | [Aminoglycoside antibiotics from clinical viewpoint]. | Int J Clin Pharmacol Biopharm | 1975 | https://conductscience.org/library/papers/1095500 | PubMed |
| 13 | 672,591 | [Kidney tolerance of cephalosporin antibiotics: cephoxitin and HR 756, experimental studies]. | Med Welt | 1978 | https://conductscience.org/library/papers/672591 | PubMed |
| 14 | 795,372 | Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/795372 | PubMed |
| 15 | 6,252,154 | Treatment of acute exacerbations of chronic bronchitis with cefotaxime: a controlled clinical trial. | J Antimicrob Chemother | 1980 | https://conductscience.org/library/papers/6252154 | PubMed |
| 16 | 423,751 | [Clinical experience with a new cephalosporin derivative, Cefotaxim]. | Med Welt | 1979 | https://conductscience.org/library/papers/423751 | PubMed |
| 17 | 412,648 | Antimicrobial synergism in the therapy of gram-negative rod bacteremia. | Chemotherapy | 1978 | https://conductscience.org/library/papers/412648 | PubMed |
| 18 | 108,220 | Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes. | Infection | 1979 | https://conductscience.org/library/papers/108220 | PubMed |
| 19 | 6,252,169 | Management of severe systemic infections caused by multiple resistant organisms. | J Antimicrob Chemother | 1980 | https://conductscience.org/library/papers/6252169 | PubMed |
| 20 | 406,807 | [Kidney damage due to drugs and its exact diagnosis]. | Anasthesiol Intensivmed Prax | 1977 | https://conductscience.org/library/papers/406807 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 8,314,290 | [Parenteral cephalosporins for the treatment of lower respiratory tract infections]. | Infection | 1993 | https://conductscience.org/library/papers/8314290 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6286502
GET https://conductscience.org/api/papers/v1/6286502/authors